Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases: results from the multicenter European TEDDY study

Chaparro M;Verreth A;Lobaton T;Gravito-Soares E;Julsgaard M;Savarino E;Magro F;Biron IA;Lopez-Serrano P;Casanova M;Gompertz M;Vitor S;Arroyo M;Pugliese D;Zabana Y;Vicente R;Aguas M;Shitrit ABG;Gutierrez A;Doherty G;Fernandez-Salazar L;Cadilla JM;Huguet J;O'Toole A;Stasi E;Marcos NM;Villoria A;Karmiris K;Rahier J;Rodriguez C;Palomares MDL;Fiorino G;Benitez J;Principi M;Naftali T;Taxonera C;Mantzaris G;Sebkova L;Iade B;Lissner D;Bradley IF;Roman ALS;Marin-Jimenez I;Merino O;Sierra M;Van Domselaar M;Caprioli F;Guerra I;Peixe P;Piqueras M;Rodriguez-Lago I;Ber Y;Van Hoeve K;Torres P;Gravito-Soares E;Rudbeck-Thomsen D;Bartolo O;Peixoto A;Martin G;Perez J;Garre A;Donday MG;de Carpi JM;Gisbert JP

2017-01-01